Information  X 
Enter a valid email address

Accrol Group Hldgs (ACRL)

  Print      Mail a friend

Friday 28 September, 2018

Accrol Group Hldgs

Audited Final Results and Notice of AGM

RNS Number : 2557C
Accrol Group Holdings PLC
28 September 2018

28 September 2018


Accrol Group Holdings plc

(the "Company")



Audited Final Results


Notice of Annual General Meeting


Accrol Group Holdings plc (AIM: ACRL), the leading independent tissue converter in the UK, announces that its audited financial results for the year ended 30 April 2018 are available to view on the Company's website: The Audited Final Results contain no material adjustments to the unaudited results announced on Wednesday, 26 September 2018.


Copies of the 2018 Report and Accounts together with the notice convening the 2018 Annual General Meeting, to be held at 11am on Tuesday, 30 October 2018 at Addleshaw Goddard,  1 St. Peters Square, Manchester M2 3AB, will be posted to shareholders in due course.


For further information, please contact:




Accrol Group Holdings plc


Dan Wright, Executive Chairman

Tel: +44 (0) 1254 278 844

Gareth Jenkins, Chief Executive Officer


Steve Townsley, Chief Financial Officer




Zeus Capital Limited (Nominated Adviser & Broker) 


Dan Bate / Andrew Jones            

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

Belvedere Communications Limited


Cat Valentine ([email protected])

Tel: +44 (0) 7715 769 078

Llew Angus ([email protected])



Notes to Editors


Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. 


Accrol operates from three sites:


·      A manufacturing, storage and distribution facility in Blackburn;

·      A facial tissue plant, also in Blackburn; and

·      A manufacturing, storage and distribution facility in Leyland.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t